• Dihydroethidium (DHE) in Redox Biology: Advancing Superoxide

  2026-07-08

  Explore the unique role of dihydroethidium in superoxide detection and oxidative stress assays. This article integrates advanced mechanistic insights and new research findings to empower apoptosis and cardiovascular disease research.

• SCH772984 HCl: Potent ERK1/2 Inhibitor for MAPK Pathway Rese

  2026-07-07

  SCH772984 HCl is a highly potent and selective ERK1/2 inhibitor used to dissect MAPK signaling and overcome resistance in BRAF- and RAS-mutant cancers. It exhibits nanomolar inhibition, robust antiproliferative activity in vitro and in vivo, and is a critical tool for mechanistic studies. This article details its mechanism, benchmarks, and practical workflow integration.

• Necrosulfonamide: Optimizing Necroptosis Assays in Translati

  2026-07-07

  Necrosulfonamide (NSA) delivers precise, MLKL-targeted inhibition for dissecting necroptotic cell death, enabling high-fidelity necroptosis assays in cancer and cardiovascular disease models. This article translates cutting-edge reference findings into practical, stepwise workflows and troubleshooting guidance, empowering researchers to maximize NSA’s impact in advanced cell death pathway research.

• Phosbind Acrylamide: Redefining Phosphate-Binding in Plant M

  2026-07-06

  Discover how Phosbind Acrylamide transforms phosphate-binding reagent workflows in protein phosphorylation analysis, with a unique focus on plant MAPK signaling and experimental design. Gain nuanced insights for advanced SDS-PAGE phosphorylation detection.

• Transcranial K+-Channelrhodopsin Inhibition Suppresses Seizu

  2026-07-06

  This study introduces a highly sensitive, K+-selective channelrhodopsin (HcKCR1-hs) engineered for transcranial optogenetic inhibition of neural hyperactivity. The noninvasive approach significantly reduced seizure activity in mouse models, opening new avenues for treating neurological disorders like epilepsy.

• WM-8014: Precision KAT6A Inhibitor for Cancer Biology Resear

  2026-07-05

  WM-8014 stands out as a selective, reversible KAT6A inhibitor, enabling precise oncogene-induced senescence assays and cell cycle arrest studies with minimal cytotoxicity. Its competitive acetyl-CoA site inhibition and robust selectivity profile empower advanced epigenetic research workflows—especially where pathway specificity and reproducibility are paramount.

• AIBP-LRP2–HDL Axis Regulates CXCR4+ Capillary Expansion in I

  2026-07-04

  Zhu et al. reveal that AIBP-LRP2–mediated HDL uptake limits the expansion of stem-like CXCR4+ capillary endothelial cells (CECs), constraining collateral circulation in ischemic disease. The study elucidates a two-phase mechanism underlying vascular remodeling and identifies a novel regulatory axis with therapeutic implications for peripheral artery disease.

• Affinity-Purified Goat Anti-Mouse IgG (H+L) HRP Conjugated:

  2026-07-03

  Unlock high-sensitivity immunodetection using the Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated secondary antibody. This guide delivers practical protocol enhancements and troubleshooting insights for Western blot, ELISA, and IHC, building on the latest literature and experimental breakthroughs.

• Directed Evolution of GPCRs: DREADDs and Clozapine N-oxide I

  2026-07-03

  The reference study pioneered the engineering of muscarinic GPCRs, enabling their selective activation by the inert ligand clozapine N-oxide (CNO). This approach established chemogenetic DREADD technology, providing a precise tool for dissecting signal transduction pathways and modulating neuronal activity in vitro and in vivo.

• Z-VDVAD-FMK: Applied Caspase-2 Inhibition for Apoptosis Assa

  2026-07-02

  Z-VDVAD-FMK empowers researchers to dissect caspase-2-mediated apoptosis and mitochondrial pathways with high specificity and reproducible performance. Its robust solubility and workflow compatibility, validated across diverse cell models, position it as a premium tool for mechanistic studies and translational cancer research.

• VGluT2 PVT Neuron Modulation in Paraquat-Induced PD Depressi

  2026-07-02

  This study identifies VGluT2 glutamatergic neuron subtypes in the paraventricular thalamic nucleus (PVT) as key modulators of depression in paraquat-induced Parkinson’s disease (PD) models. The work advances understanding of neural circuitry underlying PD-associated depression, highlighting new experimental approaches for circuit-specific neuronal activity modulation.

• PD0325901: MEK Inhibitor-Driven Precision in Cancer Research

  2026-07-01

  PD0325901 stands out as a potent, selective MEK inhibitor, enabling researchers to dissect oncogenic RAS/RAF/MEK/ERK signaling and precisely modulate cell fate in cancer models. This guide details actionable workflows, advanced troubleshooting, and how recent discoveries in TERT regulation can be leveraged for next-generation experimental design.

• JC-1: Advancing Translational Mitochondrial Research

  2026-07-01

  Explore how JC-1, a cationic fluorescent dye, is revolutionizing mitochondrial membrane potential assays and apoptosis detection in translational research. This article offers mechanistic insight, strategic guidance, and practical protocols for integrating JC-1 into advanced bioenergetics studies, while highlighting APExBIO’s leadership in assay quality and reliability.

• FXR Protein Phase Separation Drives β-Coronavirus Replicatio

  2026-06-30

  Li et al. (2024) demonstrate that fragile X–related (FXR) proteins, via liquid–liquid phase separation (LLPS), organize the clustering of replication organelles needed for efficient β-coronavirus proliferation. This discovery reveals a crucial host-driven mechanism in viral replication, providing new insights for antiviral research and the study of membraneless cellular organization.

• Torin2 in Cancer Research: Precision Targeting of Apoptotic

  2026-06-30

  Explore how Torin2, a potent mTOR inhibitor, advances cancer research by enabling precise interrogation of apoptosis mechanisms beyond classical mTOR signaling. This article delivers a unique integration of recent RNA Pol II–apoptosis insights with actionable assay guidance.

16988 records 1/1133 page Next 12345 下5页 Last page